Form 4: ATEC COO Sells Shares via 10b5-1 Plan

Alphatec Holdings COO Scott Lish sold 9,302 shares of common stock at $16 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Scott Lish, Chief Operating Officer of Alphatec Spine, Inc., a subsidiary of Alphatec Holdings, Inc. (ATEC), reported a sale of common stock.
• On August 13, 2025, Lish disposed of 9,302 shares of Alphatec Holdings, Inc. common stock.
• The shares were sold at a price of $16 per share.
• Following this transaction, Lish beneficially owns 665,030 shares of common stock.
• The sale was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Lish on March 14, 2025.

Sentiment

Score: 5

Explanation: Neutral. While an insider sale can be perceived negatively, the execution under a Rule 10b5-1 plan mitigates concerns about it being based on new, negative information. It's a routine personal financial management event for an executive.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by the market as it reduces insider ownership.

Future Outlook

NA

Management Comments

• The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

Industry Context

This filing details an insider transaction for Alphatec Holdings, Inc., a company operating in the medical device sector, specifically spine surgery. Insider sales are common for executives for personal financial planning, and the use of a 10b5-1 plan indicates a pre-scheduled transaction, which is a standard practice to avoid accusations of trading on material non-public information.

Stakeholder Impact

• Shareholders: May perceive a slight negative sentiment due to insider selling, though mitigated by the 10b5-1 plan.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific filing.

Key Dates

Recommendation

The insider sale by the COO, while reducing his direct ownership, was executed under a pre-arranged 10b5-1 trading plan. This suggests the sale is for personal financial planning rather than a reaction to new, adverse company developments. As such, this specific filing does not provide new information that would warrant a change in investment thesis, leading to a 'hold' recommendation based solely on this report.

Keywords

Alphatec Holdings, ATEC, Scott Lish, Insider Sale, Form 4, 10b5-1 Plan, Officer Transaction, Common Stock, Medical Devices, Spine Surgery